This suggests that higher ROS levels in mutant-RAS driven cancers enhance dependency on GSH production for survival and that SLC7A11 associated ferroptosis suppression may support mutant-KRAS driven cancer growth. This evidence concerns the gene SLC7A11 and cancer.